1Yamamoto T, Noble NA, Miller DE, et al. Increased levels of transforming growth factor- beta in HIV - associated nephropathy. Kidney Int, 1999, 55(2):579-592.
2Bodi I, Kimmel PL, Abraham AA, et al. Renal TGFbeta in HIV- associated kidney diseases. Kidney Int, 1997, 51(5) : 1568 - 1577.
3Winston JA, Bruggeman LA, Ross MD, et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med, 2001, 344(26) :1979 - 1984.
4Wali RK, Drachenberg CI, Papadimitfiou JC, et al. HIV - 1 - associated nephropathy and response to highly active antiretroviral therapy. Lancet, 1998, 352(9130). 783 - 784.
5Sothinathan R, Briggs WA, Eustace JA. Treatment of HIV- associated nephropathy. AIDS Patient Care STDS, 2001, 15(7) :363- 371.
6Eustace JA, Nuermberger E, Choi M, et al. Cohort study of the treatment of severe HIV- associated nephropathy with corticosteroids. Kidney Int, 2000, 58 (3) : 1253 -1260.
7Kimmel PL, Mishkin GJ, Umana WO. Captopril and renal survival in patients with human immunodeficiency virus nephropathy. Am J Kidney Dis, 1996, 28(2) :202 - 208.
8Bums C-C, Paul SK, Toth IR, et al. Effect of angiotensin -converting enzyme inhibition in HIV- associated nephropathy. J Am Soc Nephrol, 1997, 8 (7) : 1140 - 1146.
9Dave MB, Shabih K, Blum S. Maintenance hemodialysis in patients with HIV- associated nephropathy. Clin Nephrol, 1998, 50(6) :367- 374.
10Joseph A, Wali RK, Weinman EJ. Renal amyloidosis in AIDS. Ann Intern Med, 2000, 33(1):75.
